These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21444598)

  • 1. Rabies-prevention policy update: new reduced-dose schedule.
    Committee on Infectious Diseases
    Pediatrics; 2011 Apr; 127(4):785-7. PubMed ID: 21444598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices.
    Rupprecht CE; Briggs D; Brown CM; Franka R; Katz SL; Kerr HD; Lett SM; Levis R; Meltzer MI; Schaffner W; Cieslak PR;
    MMWR Recomm Rep; 2010 Mar; 59(RR-2):1-9. PubMed ID: 20300058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices.
    Manning SE; Rupprecht CE; Fishbein D; Hanlon CA; Lumlertdacha B; Guerra M; Meltzer MI; Dhankhar P; Vaidya SA; Jenkins SR; Sun B; Hull HF;
    MMWR Recomm Rep; 2008 May; 57(RR-3):1-28. PubMed ID: 18496505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.
    Briggs DJ; Banzhoff A; Nicolay U; Sirikwin S; Dumavibhat B; Tongswas S; Wasi C
    Bull World Health Organ; 2000; 78(5):693-8. PubMed ID: 10859864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen.
    Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS
    Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals.
    Rupprecht CE; Briggs D; Brown CM; Franka R; Katz SL; Kerr HD; Lett S; Levis R; Meltzer MI; Schaffner W; Cieslak PR
    Vaccine; 2009 Nov; 27(51):7141-8. PubMed ID: 19925944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postexposure rabies prophylaxis completed in 1 week: preliminary study.
    Shantavasinkul P; Tantawichien T; Wilde H; Sawangvaree A; Kumchat A; Ruksaket N; Lohsoonthorn V; Khawplod P; Tantawichien T
    Clin Infect Dis; 2010 Jan; 50(1):56-60. PubMed ID: 19995217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of immunity: an anamnestic response 14 years after rabies vaccination with purified chick embryo cell rabies vaccine.
    Malerczyk C; Briggs DJ; Dreesen DW; Banzhoff A
    J Travel Med; 2007; 14(1):63-4. PubMed ID: 17241256
    [No Abstract]   [Full Text] [Related]  

  • 9. Revised 4-dose vaccine schedule as part of postexposure prophylaxis to prevent human rabies.
    Mittal MK
    Pediatr Emerg Care; 2013 Oct; 29(10):1119-21;quiz 1122-4. PubMed ID: 24084614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroconversion following incomplete human rabies postexposure prophylaxis.
    Robertson K; Recuenco S; Niezgoda M; Garcia EJ; Rupprecht CE
    Vaccine; 2010 Sep; 28(39):6523-6. PubMed ID: 20637309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.
    Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C
    Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-year experience with 4-site intradermal booster vaccination with rabies vaccine for postexposure prophylaxis.
    Tantawichien T; Tantawichien T; Supit C; Khawplod P; Sitprija V
    Clin Infect Dis; 2001 Dec; 33(12):2085-7. PubMed ID: 11712097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced dose pre-exposure primary and booster intradermal rabies vaccination with a purified chick embryo cell vaccine (PCECV) is immunogenic and safe in adults.
    Roukens AH; Vossen AC; van Dissel JT; Visser LG
    Vaccine; 2008 Jun; 26(27-28):3438-42. PubMed ID: 18511158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of purified chick embryo cell anti-rabies vaccine in post-exposure treatment of animal bite cases.
    Bhardwaj M; Bhattacharya D; Chhabra M; Ichhpujani RL
    J Commun Dis; 2002 Mar; 34(1):40-2. PubMed ID: 12718340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe.
    Kamoltham T; Thinyounyong W; Phongchamnaphai P; Phraisuwan P; Khawplod P; Banzhoff A; Malerczyk C
    J Pediatr; 2007 Aug; 151(2):173-7. PubMed ID: 17643772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revision of the Thai Red Cross intradermal rabies post-exposure regimen by eliminating the 90-day booster injection.
    Khawplod P; Wilde H; Sirikwin S; Benjawongkulchai M; Limusanno S; Jaijaroensab W; Chiraguna N; Supich C; Wangroongsarb Y; Sitprija V
    Vaccine; 2006 Apr; 24(16):3084-6. PubMed ID: 16494972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative immunogenicity of 2 antirabies vaccines in a 2-1-1 post-exposure vaccination schedule].
    Landry P; Lazzaro M; Darioli R
    Praxis (Bern 1994); 1998 Sep; 87(37):1177-9. PubMed ID: 9785997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective immunogenicity study of multiple intradermal injections of rabies vaccine in an effort to obtain an early immune response without the use of immunoglobulin.
    Khawplod P; Wilde H; Tepsumethanon S; Limusanno S; Tantawichien T; Chomchey P; Ayuthaya AB; Wangroonsarb Y
    Clin Infect Dis; 2002 Dec; 35(12):1562-5. PubMed ID: 12471579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rabies virus pathogenesis in relationship to intervention with inactivated and attenuated rabies vaccines.
    Franka R; Wu X; Jackson FR; Velasco-Villa A; Palmer DP; Henderson H; Hayat W; Green DB; Blanton JD; Greenberg L; Rupprecht CE
    Vaccine; 2009 Nov; 27(51):7149-55. PubMed ID: 19925945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab).
    Ashwathnarayana DH; Madhusudana SN; Sampath G; Sathpathy DM; Mankeshwar R; Ravish HH; Ullas PT; Behra TR; Sudarshan MK; Gangaboraiah ; Shamanna M
    Vaccine; 2009 Dec; 28(1):148-51. PubMed ID: 19818720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.